Lijo C. Illipparambil, MD, MS, Assistant Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, provided perspective for a Healio Pulmonology article about a study presented at the American Thoracic Society International Conference that found dupilumab decreases exacerbation rate and improves lung function in patients with COPD type 2 inflammation.